A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin

NCT ID: NCT06579742

Last Updated: 2024-08-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-07

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a triple-blinded, randomized, placebo-controlled clinical trial designed to evaluate the efficacy of Scale Media's Live Conscious Beyond Collagen supplement on overall hair and skin health. The study will involve 50 male or female participants aged 40 and over who have self-perceived hair thinning and shedding. The trial will last for 24 weeks and includes the completion of questionnaires and photo submissions at specific time points.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hair Thinning Hair Loss

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Skin Aging Loss of Skin Elasticity Skin Health Hair Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Live Conscious Beyond Collagen Supplement

Participants in this arm will receive the Live Conscious Beyond Collagen supplement. The supplement contains Vitamin C (90 mg), Biotin (2500 mcg), and a Proprietary Collagen Blend (10.1 g) including Types I \& III Bovine Collagen, Type II Marine Collagen, Type II Chicken Sternum Collagen, and Types I, V \& X Eggshell Membrane Collagen.

Group Type EXPERIMENTAL

Live Conscious Beyond Collagen

Intervention Type DIETARY_SUPPLEMENT

Participants in the experimental arm will take 1 scoop (10.4 g) of Live Conscious Beyond Collagen supplement mixed with 12 fl oz of water in the evening after their last meal of the day for 24 weeks.

Placebo

Participants in this arm will receive a placebo product. The placebo contains Maltodextrin.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Participants in the placebo comparator arm will take 1 scoop (10.4 g) of the placebo product (Maltodextrin) mixed with 12 fl oz of water in the evening after their last meal of the day for 24 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Live Conscious Beyond Collagen

Participants in the experimental arm will take 1 scoop (10.4 g) of Live Conscious Beyond Collagen supplement mixed with 12 fl oz of water in the evening after their last meal of the day for 24 weeks.

Intervention Type DIETARY_SUPPLEMENT

Placebo

Participants in the placebo comparator arm will take 1 scoop (10.4 g) of the placebo product (Maltodextrin) mixed with 12 fl oz of water in the evening after their last meal of the day for 24 weeks.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female or male
* Self-perceived hair thinning, specifically on the top and crown of the scalp for at least three months
* Self-perceived increased hair shedding for at least three months
* Concerns regarding skin health and appearance
* Has been using the same hair care routine and products for at least one month prior to the study, i.e., shampoo, conditioner, and products
* Has been using the same skincare routine and products for at least one month prior to the study, i.e., moisturizer, serums, etc.
* Willing to maintain the same hair care routine and products throughout the study
* Willing to maintain the same skincare routine and products throughout the study
* Willing to maintain the same diet and exercise regimen during the study
* Willing to refrain from taking any vitamins, minerals, or herbal supplements that target hair growth or skin health during the study
* Willing to refrain from taking any new vitamins, minerals, or supplements of any kind during the study
* Willing to avoid introducing any new prescription medications or supplements that target hair health and appearance of skin health and appearance during the study
* Be generally healthy and do not live with any uncontrolled chronic disease
* Willing to stop taking any other multivitamin supplements at least one month prior to and for the entire study duration
* Willing to avoid dyeing the hair for the duration of the study
* Living with someone who can take their study photos for the duration of the study

Exclusion Criteria

* Anyone with a diagnosed hair loss or hair thinning health condition, except for female pattern baldness (e.g., alopecia areata)
* Women who are pregnant, breastfeeding, or trying to conceive
* Anyone currently taking iron supplements
* Anyone unwilling or unable to follow the study protocol
* Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
* Anyone who does not consume animal products for personal or religious reasons
* Is undergoing or planning to undergo laboratory testing and/or significant medical procedures during the study duration
* A history of severe allergic reactions, including but not limited to any of the product's ingredients
* Has undergone any chemical treatments to the hair in the last three months, e.g., chemical straightening, hair extensions with chemical bonding, perms, and relaxers
* Has any planned chemical treatments for the hair during the study period, e.g., chemical straightening, hair extensions with chemical bonding, perms, and relaxers
* Has any planned cosmetic treatments to the face, including botox, dermal filler, chemical peels, etc.
* Currently undergoing hair loss treatment, including mechanical scalp stimulation, or has done so in the last three months
* Currently using other hair growth/thickening products
* Currently taking any prescription medication for hair loss, or has done so in the last three months
* Currently taking any prescription medication for skin health, or has done so in the last three months
* Has undergone any surgeries or invasive treatments in the last six months
* Has had any major illness in the last three months
* Currently taking medication that has hair loss as a known or observed side effect
* Currently undergoing or have you recently undergone chemotherapy or radiotherapy
* Anyone who has had a hair transplant within the last year
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Citruslabs

INDUSTRY

Sponsor Role collaborator

Scale Media Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Citruslabs

Santa Monica, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20423

Identifier Type: -

Identifier Source: org_study_id